Press Releases Eli Lilly and Company Borsa Italiana

Equities

4LLY

US5324571083

Real-time Estimate Tradegate Other stock markets 09:58:38 17/07/2024 pm IST			5-day change	1st Jan Change
841 ^EUR	-3.78%		+2.14%	+66.00%

06:24pm	Global markets live: Adidas, TSMC, Vale, HSBC, J&J...
03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	12/07	AQ
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion - InsideArbitrage	10/07	AQ
Weight loss drug Zepbound outperforms Ozempic in new published study	09/07	AQ
Lilly agrees $3.2b IBD acquisition	08/07	AQ
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024	03/07	AQ
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	27/06	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	27/06	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	25/06	PR
Lilly Declares Third-Quarter 2024 Dividend	24/06	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	20/06	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	20/06	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	20/06	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	08/06	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	05/06	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	05/06	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	03/06	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	31/05	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	29/05	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 13, 2024 at 12:17 am IST